To homepage

Page 11 - Best oncologists: TOP 656 doctors

Content meets the Bookimed Editorial Policy and is medically reviewed by

Yesim Yildirim

Ferah Ece

  • 4.5 Good 234 reviews
  • 28 years of experience
  • Turkey, Istanbul, Liv Hospital Ulus
    1. Medical Interests and Activities 
    2. • Lung Cancer (Postdoctoral fellowship, MD Anderson Cancer Center, Houston, TX, USA)
    3. • Interventional Bronchoscopy (Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, USA)
    4.  
    5. Education and Experience 
    6. • Department of Thoracic Diseases, Liv Hospital, Ulus
    7. • Faculty of Medicine, İstanbul Bilim University
    8. • Ministry of Health Süreyyapaşa Thoracic Diseases Training and Research Hospital
    9. • Faculty of Medicine, Marmara University Memberships
    10. • IASLC (International Association for the Study of Lung Cancer)
    11. • ACCP (American College of Chest Physicians)
    12. • TAKD (Turkish Lung Cancer Society) (Executive Board Member)
    13. • TTD (Turkish Thoracic Society)
    14. • TÜSAD (Turkish Respiratory Research Society)
    15.  
    16. Memberships 
    17. • IASLC (International Association for the Study of Lung Cancer) 
    18. • ACCP (American College of Chest Physicians) 
    19. • TAKD (Turkish Lung Cancer Society) (Executive Board Member) 
    20. • TTD (Turkish Thoracic Society) 
    21. • TÜSAD (Turkish Respiratory Research Society) 
    22.  
    23. Researches and Publications 
    24. • International: 48 
    25. • National: 60 
    26. • Authorship for Books and Book Chapters at National Level: 4 
    27. • Medical Fellowship, TEV Orhan Birman, MD 1998 
    28. • “Fellow in American College of Chest Physicians” Title, 2009 
  • Read more
Info

Deniz Konya

  • 4.4 Good 30 reviews
  • 75 years of experience
  • Turkey, Istanbul, Medical Park Göztepe Hospital Complex
  • Spinal neurosurgeon

Gastroectomy
$15,600 - $15,600
Info

Tahsin Ozatli

  • 4.4 Good 17 reviews
  • 2015 years of experience
  • Turkey, Istanbul, Istinye University Liv Hospital Bahcesehir
  • Oncologist
Brain tumor surgery
$15,000 - $18,000
Colectomy (large bowel resection)
$8,650 - $16,000
Chemotherapy for uterine cancer
$2,000 - $8,000
Info

Yusuf Acikgoz

  • 4.9 Excellent 7 reviews
  • 9 years of experience
  • Turkey, Ankara, Lokman Hekim University Ankara Hospital
  • Associate Professor Dr. Yusuf AÇIKGÖZ
    Specialization: Medical Oncology

    Education:

    • 2004-2011: İnönü University Faculty of Medicine
    • 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
    • 2017-2022: Health Sciences University, Medical Oncology

    Professional Experience:

    • 2016-2017: Bingöl City Hospital, Internal Medicine
    • 2021-2022: Health Sciences University, Medical Oncology
    • 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
    • 2023-2024: Ohio State University, Medical Oncology
    • 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital

    Clinical Trials, Courses, Certifications:

    Clinical Trials:

    • 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
    • 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)

    Courses:

    • 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
    • 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
    • 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
    • 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
    • 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association

    Certifications:

    • Ongoing: ECFMG Certification
    • 2024: CITI Responsible Conduct of Research (The Ohio State University)
    • 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
    • 2024: CITI Human Subjects Protection (The Ohio State University)
    • 2024: CITI Good Clinical Practice (The Ohio State University)
    • 2023: Occupational English Test (OET)
    • 2019: International English Language Testing System (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
    • 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
    • 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016

    Memberships:

    • American Society of Clinical Oncology (ASCO) - 2022
    • Turkish Society of Medical Oncology - 2020
  • Read more
Robotic da Vinci prostatectomy
$10,120 - $11,760
Lung cancer surgery
$10,940 - $16,410
Radiofrequency ablation
$5,470 - $10,390
Info

Reuven Or

  • 4.4 Good 12 reviews
  • accreditations:
  • Israel, Jerusalem, Hadassah Medical Center
  • Prof. Dr. Reuven Or is a highly experienced hematologist and bone marrow transplant specialist from Italy, USA and Israel with a MD degree from the University of Milan, certificate for an associate professorship from the Hebrew University of Jerusalem, senior physician and head of the Department of Hematology, Cancer Immunotherapy, Cell Therapy, and Bone Marrow Transplantation at Hadassah Hebrew University Hospital, Medical Director of Hadassah Public Bone Marrow Registry and the Israeli National Blood Bank, several published articles in medical journals, and the Menachem Begin Prize in 2008.
  • Read more
Info

Dr Murat Ayhan

  • 5 Excellent 7 reviews
  • 35 years of experience
  • Turkey, Istanbul, Liv Hospital Vadistanbul
  • Areas of Interests

    • Breast cancer
    • Lung cancer
    • Colorectal cancers
    • Gynecological and urogenital cancers
    • Molecular Oncology

    Education:

    • Kızıltepe Anatolian High School 2001
    • Dicle University Faculty of Medicine 2007
    • Istanbul Medeniyet University Göztepe Training and Research Hospital 2014
    • Kartal City Hospital 2021
    • Associate Professor of Medical Oncology 2023

    Experience:

    • Liv Hospital Ulus
    • Adıyaman University Training and Research Hospital
    • Istanbul Umraniye Training and Research Hospital
    • Istanbul Umraniye Training and Research Hospital

    Research:

    • Phase II, Randomized, Open-Label, Multicenter Study to Comparatively Evaluate the Efficacy and Safety of GDC-9545 and Physician-Preferred Endocrine Monotherapy in Previously Treated, Estrogen Receptor Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer Patients, Other ( International), Dr. Murat Ayhan
    • Phase III, Randomized, Evaluating the Efficacy and Safety of Palbociclib and Fulvestrant with Gdc-0077 Compared with Placebo in Patients with Pik3ca-Mutant, Hormone Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer. Double Blind, Placebo Controlled Study, Other (International), Dr. Murat Ayhan
    • Randomized, Multicenter, Phase Ib/III Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Atezolizumab Compared to Intravenous Atezolizumab in Patients with Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer, Other (International) Dr. Murat Ayhan
    • Randomized, Controlled, Multicenter, Open-Label Study Including Observation Follow-Up for PSMA-PET-Negative Patients, Investigating the Efficacy and Safety of Addition of Apalutamide to Radiotherapy and LHRH Agonist in PSMA-PET-Positive High-Risk Hormone-Sensitive Prostate Cancer Patients, Other (International) Dr. Murat Ayhan
    • Biomarker Study to Identify Patients with Advanced Stage Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations-42756493BLC0002, Other (International), Dr. Murat Ayhan
    • Publications:
    • Ayhan M, Turan N, Köstek O, et all. Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology? Curr Probl Cancer. 2021 Jun;45(3):100670. doi: 10.1016/j.currproblcancer.2020.100670.
    • Ayhan M, Odabas H, Turan N, et all. Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19: a single center's experience. J Chemother. 2021 Nov;33(7):499-508. doi: 10.1080/1120009X.2021.1923153.
    • Ayhan M, Laçin Ş, Özyükseler DT, et all. Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer? J Oncol Pharm Pract. 2021 Sep;27(6):1461-1467. doi: 10.1177/10781552211015762.
    • Ayhan M, Abamor E, Coban Kokten S, et al. Value of FDG PET/CT in Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer. EJMI 2022;6(2):165–175.
    • Ayhan M, Terzioglu K. Experience With Rapid Drug Desensitization With Chemotherapeutics; A SingleCentre Retrospective Study. EJMI 2021;5(3):380–387.
    • Doğan A, AYHAN M. Survival analysis of patients with triple-negative breast cancer: a single-center experience. Journal of Oncological Sciences, 8(2), 94-99., Doi: 10.37047/jos.2022-89749
    • Terzioğlu K, Ayhan M. Comparative Assessment of Platinum Salts and Taxane Group Hypersensitivity Reactions, The Role of Skin Tests in Diagnosis? J Oncol Pharm Pract. 2021 Nov 30:10781552211050084. doi: 10.1177/10781552211050084.
    • Tacar SY, Selcukbiricik F, Yilmaz M, Erturk K, Murat Sarici A, Gulturk I, Ayhan M, Tural D. Nivolumab for metastatic uveal melanoma: a multicenter, retrospective study. Melanoma Res. 2021 Oct 1;31(5):449-455. doi: 10.1097/CMR.0000000000000744.
    • Özyurt E, Özçelik S, Sürmeli H, Çelik M, Ayhan M, Özçelik M. Side effects of immune-checkpoint inhibitors: Can multiple side effects be seen in a patient? J Oncol Pharm Pract. 2022 Mar;28(2):462-465. doi: 10.1177/10781552211038136.
    • Dülgar Ö, Öven BB, Atcı MM, Arıkan R, Ay S, Ayhan M, Selvi O, Ozyukseler DT, Bayram E, Özcan E, Yasin Aİ, Gümüş M. Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy? Expert Rev Anticancer Ther. 2022 Jul;22(7):773-780. doi: 10.1080/14737140.2022.2076670.
    • Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study. J Cancer Res Clin Oncol. 2022 Jun;148(6):1501-1508. doi: 10.1007/s00432-021-03748-7.
    • Volume I, Kucukarda A, Atcı MM, Ayhan M, et all. Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study. Tumori. 2022 Feb;108(1):19-25. doi: 10.1177/03008916211037739.
    • Dogan I, Ayhan M, Gurbuz M, et all. The frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter study. Medicine (Baltimore). 2022 Sep 2;101(35):e30147. doi: 10.1097/MD.0000000000030147.
    • Ozcelik M, Oyman A, Cil I, Duzgun O, Ozkan OF, Ayhan M. Cytoreductive Surgery versus Systemic Chemotherapy alone in Isolated Peritoneal Carcinomatosis of Colorectal Origin. J Coll Physicians Surg Pak. 2021 Nov;31(11):1308-1313. doi: 10.29271/jcpsp.2021.11.1308.
    • Başoğlu T, Sakin A, Erol C, Ayhan M, et all. Real life experienceof patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study. J Chemother. 2022 May 17:1-8. doi: 10.1080/1120009X.2022.2073159.
    • Özdemir Ö, Zengel B, Yildiz Y, Ayhan M, et all. The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study. Anticancer Drugs. 2022 Aug 1;33(7):663-670. doi: 10.1097/CAD.0000000000001310.
    • Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study). J Cancer Res Clin Oncol. 2022 Sep 1. doi: 10.1007/s00432-022-04252-2.
    • Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study. Future Oncol. 2022 Jul;18(23):2573-2582. doi: 10.2217/fon-2022-0083.
    • Topcu A, Atci MM, Secmeler S, Besiroglu M, Ayhan M, Ozkan M, Bozkurt O, Urakci Z, Ay S, Geredeli C, Yasin AI, Turk HM. Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer. Future Oncol. 2021 Nov;17(31):4157-4169. doi: 10.2217/fon-2021-0398.
    • Bilgin B, Sendur MAN, Yucel S, Ayhan M, et all. Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study. J Cancer Res Clin Oncol. 2021 Jul;147(7):2145-2152. doi: 10.1007/s00432-020-03501-6.
    • Atci MM, Akagunduz B, Demir M, Arikan R, Ay S, Ozer M, Ayhan M, Cil I, Demir N, Ozyurt N, Karakaya G, Cevik GT, Onder AH, Selvi O, Sakin A. The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study. J Chemother. 2023 Feb;35(1):19-28. doi: 10.1080/1120009X.2022.2040770.
    • Tataroglu Ozyukseler D, Ay S, Turan M, Alkan G, Ayhan M, Surmeli H, et al. The Systemic Inflammation Response Index as a Prognostic Marker in Advanced Pancreatic Cancer. EJMI 2022;6(3):367–373.
    • Yıldız F, Ayhan M, Demir H, et all. Comparing the efficacy of cabazitaxel in secondline and third-Line treatment of metastatic castration-resistant prostate cancer: a multi-center experience from Turkey. International Journal of Contemporary Medical Research, 7(9), 112-116.,Doi: 10.21276/ijcmr.2020.7.9.30
    • Terzioğlu K, Ayhan M. Distribution of allergens detected on patch tests of patients with allergic contact dermatitis and investigation of their atopic background. Annals of Medical Research, 29(5), 422-426., doi: 10.5455/annalsmedres.2021.07.490
    • Arikan R, Atci MM, Ay S, Ayhan M, et all Prognostic significance of mucinous histology in left sided metastatic colorectal cancers with wild type RAS and evaluation of backbone chemotherapy regimens. Oncol Lett. 2023 Apr 5;25(5):208. doi: 10.3892/ol.2023.13795.
    • Almuradova E, Yalcin S, Arıkan R, Ayhan M, Demir H, Cevik GT, Karaca M, Petekkaya I, Karabulut B. Survival of Patients With Metastatic Rectum Cancer Who Underwent Metastasectomy Following Conversion Chemotherapy Sans Pelvic Radiotherapy: A Turkish Oncology Group Study. Cureus 2023 May 17;15(5):e39119. doi: 10.7759/cureus.39119.
    • Topcu A, Besiroglu M, Atci MM, Ayhan M, et all. Second-line Therapy after Trastuzumab Failure in HER2-Positive Metastatic Gastric Cancer: A Real-life Data. EJMI 2023;7(2):153–161. DOI: 10.14744/ejmi.2023.22720
    • Book Writing:
    • Drug interactions and side effects of targeted agents, Section name: (Small molecule tyrosine kinase inhibitors; ROS-1 targeted therapies (Crizotinib, Seritinib)) (2021)., AYHAN MURAT, Turkish Clinics Journal of Medical Sciences, Editor: Mehmet Aliustaoglu, Publishing number:1, Number of Pages 92, ISBN:978-625-401- 466-6, Turkish
    • Approach to gastrointestinal stromal tumors and neuroendocrine tumors, Department name: (Medical approach in primary non-gastrointestinal neuroendocrine tumors) (2020)., AYHAN MURAT, Akademisyen Yayınevi, Editor: Anılır Ender, Number of editions: 1, Number of Pages 382, ISBN: 9786052585719, Turkish
    • Internal medicine emergencies, Department name: (Oncological emergencies) (2022)., YILDIRIM SEDAT, AYHAN MURAT, Efe Academic Publishing, Editor: Serdar Olt, Number of editions: 1, Number of Pages 232, ISBN: 978-625-8324-66- 2, Turkish
    • Physicians' chemotherapy cancer drug manual 2020, Section name: (Common chemotherapy regimens in clinical practice) (2022)., SÜMBÜL AHMET TANER, ALKAN ALI, AKSOY ASUDE, AYHAN MURAT, et all, Türkiye Klinikleri Journal of Medical Sciences, Editor: EDWAR CHU, VINCENT T. DEVITA, SAADDETIN KILIÇKAP, CEMIL BILIR, SELÇUK SEBER, Number of editions: 1, Number of pages 772, ISBN: 978-625-401-290- 7, Turkish (Book Translation)

     

  • Read more
Chemotherapy
$3,000 - $3,500
Info

Ercan Ozden

  • 5 Excellent 1 review
  • 26 years of experience
  • Turkey, Istanbul, VM Medical Park Pendik Hospital
  • Dr. Ercan Ozden is a specialist in internal medicine and medical oncology. He earned his medical degree and completed his residency at Istanbul University, Cerrahpaşa Faculty of Medicine. He later received a subspecialty in medical oncology at Kocaeli University Faculty of Medicine from 2016 to 2020.

    Dr. Ozden has worked in medical oncology at Şırnak State Hospital. He has also served as an internal medicine specialist at Bağcılar Private Safa Hospital and Küçükçekmece Batı Bahat Hospital. He has extensive clinical experience in both internal medicine and oncology.

  • Read more
Brain tumor removal
$12,000 - $15,000
Mastectomy
$6,500 - $8,000
Info

Gul Alco

  • 5 Excellent 3 reviews
  • 30 years of experience
  • Turkey, Istanbul, Medipol Acibadem District Hospital
  • Education

    • 1986-1989, Bursa High School, Bursa, Turkey
    • 1989-1995, Istanbul University, Istanbul School of Medicine, Turkey
    • 1999-2003, (Residency) Kadir Has University, School of Medicine, Department of Radiation Oncology, Istanbul, Turkey
    • 2015, (Associate Professor) Demiroglu Bilim University, Department of Radiation Oncology, Istanbul, Turkey
    • 2021, (Professor) Demiroglu Bilim University, Department of Radiation Oncology, Istanbul, Turkey
    • 2024, Istanbul Medipol University, Department of Radiation Oncology, Istanbul, Turkey

    Experience

    • 1995-1999, Şişli Florence Nightingale Hospital, Istanbul, Cardiology Department
    • 2003, Gayrettepe Florence Nightingale Hospital, Istanbul, Department of Radiation Oncology
    • 2015, (Associate Professor in Radiation Oncology) Demiroglu Bilim University, Department of Radiation Oncology, Istanbul, Turkey
    • 2021, (Professor in Radiation Oncology) Demiroglu Bilim University, Department of Radiation Oncology, Istanbul, Turkey
    • 2024, Istanbul Medipol University, Department of Radiation Oncology, Istanbul, Turkey
  • Read more
Doctor's visit
Price on request
Info

Osman Kostek

  • 5 Excellent 3 reviews
  • 21 years of experience
  • Turkey, Istanbul, Medipol Acibadem District Hospital
  • Education

    • (2004 – 2011), Faculty of Medicine/ Inonu University/ Malatya, Turkiye
    • (2011 – 2015), Department of Radiology/ Bagcilar Training and Research Hospital/ Istanbul, Turkiye

    Career

    • (2016 – 2020), Diagnostic and Interventional Radiologist/ Mus State Hospital/ Mus,Turkiye
    • (2020 – 2022), Assistant Professor of Diagnostic and Interventional Radiology/ Sakarya University Training and Research Hospital/ Sakarya, Turkiye
    • (2023 – 2024), Associate Professor of Diagnostic and Interventional Radiology /Sakarya University Training and Research Hospital/ Sakarya, Turkiye
    • (2024 - Present), Associate Professor of Diagnostic and Interventional Radiology /Medipol University Hospital/ Istanbul, Turkiye
  • Read more
Doctor's visit
Price on request
Info

Lee Ji Hyun

  • New
  • 38 years of experience
  • Republic of Korea, Incheon, Jian Health Promotion Center Health Сheck-Up (By Na-Eun Hospital and Heartner International Medical Center)
  • Lee Ji Hyun, MD, is a breast and thyroid surgeon. Dr. Lee is Head of Breast and Thyroid Surgery at Naeun Hospital. Clinical focus includes benign breast disease, breast cancer, and tumor surgery. Additional areas include benign thyroid disease, thyroid cancer, and parathyroid disorders. Skills include Mammotome procedures, axillary node management, and breast and thyroid ultrasound.

    Education and training: Yonsei University College of Medicine. Internship and general surgery residency at Yonsei University Severance Hospital. Short-term clinical training at the Affiliated Hospital of the Cancer Research Institute in Japan.

    Key roles: Chief of General Surgery at Incheon Christian Hospital and General Surgery Specialist at Cheil Hospital. Director of the Breast Center and Chief of the Department of Surgery at Samsung Cheil Hospital. Chief of General Surgery and Deputy Director of Clinical Services at Cheil Hospital. Outpatient Professor of Surgery at CHA Gangnam Medical Center, CHA University. Chief of General Surgery at Daejeong Hospital.

  • Read more
Doctor's visit
Price on request
Info

Dr Cevat Azeroglu

  • New
  • 38 years of experience
  • Turkey, Istanbul, ÜMRAN TIP MERKEZİ
  • Dr. Cevat Azeroglu is a radiologist. He graduated from the Tabriz University Faculty of Medicine in 1987. He completed his radiology specialization at Ondokuz Mayıs University in 2011. Born in 1959, he provides advanced imaging to support accurate, timely decisions for many specialties.

    His expertise includes conventional radiology with X-rays for musculoskeletal and chest disease. He performs ultrasound of the abdomen, thyroid, vessels, and soft tissues. He interprets CT and MRI for neurological, cardiovascular, and oncologic conditions. He practices interventional radiology with image-guided, minimally invasive procedures. He also focuses on oncologic imaging for staging and follow-up. He is known for diagnostic precision, use of modern imaging tools, and strong teamwork.

  • Read more
Doctor's visit
Price on request
Info

Dr Derya Zengin Metli

  • New
  • 10 years of experience
  • Turkey, Istanbul, ÜMRAN TIP MERKEZİ
  • Dr. Derya Zengin Metli is a physician specialized in physical therapy and rehabilitation. She graduated from Akdeniz University Faculty of Medicine. Her practice includes physical therapy and physiotherapy services. She also consults in English.

    Her clinical scope includes musculoskeletal rehabilitation for back, neck, and joint pain, and herniated discs. She provides neurological rehabilitation for stroke and multiple sclerosis. She also offers post-surgical rehabilitation after orthopedic and neurosurgical procedures, sports injury prevention and treatment, and chronic pain management for fibromyalgia and arthritis.

  • Read more
Doctor's visit
Price on request
Info

Ms Yaren Nur Gungor

  • New
  • 7 years of experience
  • Turkey, Istanbul, ÜMRAN TIP MERKEZİ
  • Dyt. Yaren Nur Güngör is a dietitian. She graduated from the Faculty of Nutrition and Dietetics. She provides evidence-based, personalized nutrition counseling in English. She designs tailored programs for health promotion, disease management, and weight control.

    Her clinical focus includes diet plans for diabetes, heart disease, thyroid disorders, and other metabolic issues. She also guides weight loss and gain and improves body composition. She offers sports nutrition and nutrition care for children and teens. She provides preventive nutrition with lifestyle counseling. Her approach is patient-centered and motivating.

  • Read more
Doctor's visit
Price on request
Info

Dr Ozlem Yogurtcu

  • New
  • 35 years of experience
  • Turkey, Istanbul, ÜMRAN TIP MERKEZİ
  • Dr. Ozlem Yogurtcu is a general surgeon with extensive experience. She graduated from Dokuz Eylul University Faculty of Medicine. She completed her general surgery residency at Haseki Training and Research Hospital, 1st Surgical Clinic. She is fluent in English.

    Her practice includes gastrointestinal surgery (gallbladder disease, hernias, appendicitis, other gastrointestinal conditions). It also includes endocrine surgery (thyroid, parathyroid, adrenal) and breast surgery (benign and malignant conditions). She treats emergency and trauma cases. She performs minimally invasive laparoscopic procedures.

    She is known for precise surgery and a patient-centered approach.

  • Read more
Doctor's visit
Price on request
Info

Dr Erdem Gelegen

  • New
  • 21 years of experience
  • Turkey, Istanbul, ÜMRAN TIP MERKEZİ
  • Dr Erdem Gelegen is an ophthalmologist with over 20 years of experience in cataract, refractive, retinal, glaucoma, and corneal/anterior segment care. He performs phacoemulsification with premium intraocular lenses. He provides laser vision correction for myopia, hyperopia, and astigmatism. He treats diabetic retinopathy, age-related macular degeneration, retinal detachment, keratoconus, and anterior segment disorders, including corneal transplants.

    He graduated from Istanbul University Cerrahpaşa Faculty of Medicine in 1999. He completed his ophthalmology residency at Okmeydanı Training and Research Hospital in 2004. He is known for precise microsurgery and the use of advanced ophthalmic technologies.

  • Read more
Doctor's visit
Price on request
Info

Praewfun Surachai

  • New
  • 8 years of experience
  • Thailand, Bangkok, PYONG Rehabilitation Group
  • Dr Praewfun Surachai is a general obstetrician-gynaecologist focused on gynaecology and reproductive medicine. She completed her OBGYN residency at Ramathibodi Hospital from 2020 to 2023. She is now a fellow in the Reproductive Medicine Unit (2024–present). She earned her MD from the Faculty of Medicine Ramathibodi Hospital, Mahidol University (2011–2017).

    Experience: General obstetrician-gynaecologist and lecturer at Pranangklao Hospital, Nonthaburi (2023–2024). General practitioner at Angthong Hospital and Wisetchaichan Hospital, Angthong (2017–2020).

    Achievements: MC at the Menopause Academic Conference 2025, Bangkok. Popular-vote Resident Award (2021). Certificate of Outstanding Teaching Performance (2021). iPoster presentation at the RCOG World Congress (2019). Certificate of attendance in Basic Principles and Teaching Techniques, Siriraj (2023).

  • Read more
Doctor's visit
Price on request
Info

Luna Kaduri

  • 4.4 Good 12 reviews
  • 30 years of experience
  • Israel, Jerusalem, Hadassah Medical Center
  • RESEARCH ACTIVITY

    1998–2000 — Conducted research on the genesis of cancer at The Royal Marsden Hospital (England).

    PUBLICATIONS

    Authored numerous peer-reviewed articles in scientific journals. Selected topics include:

    Oncotype Dx Recurrence Score in BRCA1/2 germline mutation carriers with hormone receptor-positive breast cancer.

    TP53 missense mutation recurrence in cancer patients of Arab descent.

    Adjuvant autologous vaccine for stage III microscopic melanoma: biomarker survival and enhanced response to CTLA-4 blockade.

    Prognostic significance of (R)CA15-3 assay in primary breast cancer.

    Diagnostic and prognostic value of comparative thymidine kinase 1 (TK1) activity assays in breast cancer patient serum.

    Complete remission in a BRCA2 mutation carrier with metastatic pancreatic adenocarcinoma treated with cisplatin.

    Autologous vaccine-induced antitumor and self-reactive immune responses in melanoma: impact on patient survival and dependence on MHC class II expression.

    PROFESSIONAL AFFILIATIONS

    Israeli Society of Clinical Oncology

    Israel Medical Association

    AWARDS & GRANTS

    Cancer Genetics Research Foundation Award

    Landau Prize

    Judith Segal Memorial Award

  • Read more
Info

Aaron Popovcer

  • 4.4 Good 12 reviews
  • 22 years of experience
  • Israel, Jerusalem, Hadassah Medical Center
  • Core Specializations

    Oncology:

    Head and neck tumors

    Thyroid cancer

    Personalized biological and immunotherapy

    Treatment of recurrent cancer and spinal metastases

    Radiotherapy

    Education

    1998 — Graduated from the Faculty of Medicine at the Hebrew University (Jerusalem, Israel).
    2016 — Six-month advanced training course in radiosurgery with a special focus on modern methods of focused radiotherapy for spinal and malignant thyroid tumors at Memorial Sloan Kettering Cancer Center (New York, USA).

    Professional Experience

    1998–1999 — Internship at Hadassah University Hospital (Jerusalem, Israel).
    1999–2005 — Specialization in the Department of Otolaryngology and Head & Neck Surgery at Rabin Medical Center (Petah Tikva, Israel).
    2005–2009 — Specialization in oncology and radiotherapy at the Davidoff Cancer Center (Rabin Medical Center).
    2006–2008 — Fellowship at the University of Michigan (Ann Arbor, USA) in multidisciplinary cancer treatment.
    2008 — Fellowship in head and neck tumor brachytherapy at Beth Israel Medical Center (New York, USA).
    2009–2012 — Head of the Head and Neck Oncology Clinic at the Davidoff Cancer Center.
    2013–2019 — Chief of the Head and Neck Oncology Division and Deputy Head of the Radiotherapy Department at the Davidoff Cancer Center.
    Since 2019 — Director of the Oncology Department and Sharett Cancer Institute at Hadassah University Hospital.

  • Read more
Info

Gerald Raphael Tur

  • New
  • 14 years of experience
  • Thailand, Bangkok, Vega Clinic
  • Doctor of Osteopathy from National University of Medical Sciences – Registration S1702131.

    Bachelor of science in Osteopathy from National University of Medical Sciences – Registration S1702131.

    Certified from “Union of Thai Traditional Medicine Society” – Registration 112460.

    Acupuncturist – Certified by Chinese Republic and signed by Notary – Registration 140013.

    Member of the International Osteopathic Association (IOA).

    Official representative of Osteopathy Chronic Pain Clinics of Canada (OCPCC) in Phuket – Thailand.

    Gonstead Chiropractic techniques (inc Knee chest table).

    Diploma in Osteopathic & Chiropractic full course online.

    Certified Emergency first responder + CPR & AED (valid until 12/2026)

    Member of the Swiss Medical Register (RME) – Registration B330879.

    Member of the Association of Swiss Health Insurances - Registration 6178.

    Certified in Chinese Pharmacology.

    Certified in Chinese Psychiatric.

    Certified in Chinese Nutrition.

  • Read more
Doctor's visit
Price on request
Info

Panayiotis Kyzas

  • New
  • 20 years of experience
  • Cyprus, Republic of Cyprus, German Medical Institute (GMI)
  • Professor Kyzas completed his PhD thesis in H&N Cancer with Honours (Αριστα), producing several highly cited influential publications. He has published > 70 scientific papers in high impact journals and has > 6000 citations.

    Following his studies, Professor Kyzas has undertaken postgraduate training in the UK and was successful in securing a very competitive training post in the UK Higher Specialty Training Programme for Oral and Maxillofacial Surgery. He was trained in some of the biggest University Teaching hospitals in the North West of the UK. He has been awarded the Certificate of Completion of Training (CCT) in Oral and Maxillofacial Surgery by the General Medical Council (GMC). Subsequently, he was successful in securing one of the very few and prestigious UK-wide Training Interface (TIG) Fellowships in Head and Neck Surgical Oncology. He has successfully completed his fellowship and was awarded the subspecialty of Head and Neck Surgery by the Joint Committee of Surgical training (JCST).

    In 2014 he has been appointed as a permanent substantive Consultant in Oral and Maxillofacial/Head and Neck Surgery in Manchester. He has treated hundreds of patients with Head and Neck cancer, offering state of the art major ablative and reconstructive surgery. He specialises in microvascular free tissue transfer and he has introduced and developed the 3D printer – personalised planning (PSP) reconstructive surgery in his hospital. He led his unit to become a reference centre by having the highest number of successful 3D PSP cases in the UK. Besides head and neck cancer, Professor Kyzas offers treatment to patients with facial skin cancer, oral and maxillofacial trauma, dentoalveolar surgery, orthognathic surgery, salivary gland diseases, facial cosmetic surgery, surgery of the temporomandibular joint, and anything else within the broad spectrum of Oral and Maxillofacial Surgery. He has performed many thousands of surgical procedures and has vast experience in any oral and maxillofacial condition. He has a special interest in the use of laser for oral pathologies and he is the Principal Investigator for an international trial examining the effectiveness of Transoral Laser resection in Ηead and Νeck Cancer. He is a certified microvascular surgeon and has accreditation in advanced trauma life support (ATLS).

    Just before the covid pandemic, Professor Kyzas was presented with a unique opportunity to lead on the development of a Head and Neck Cancer Service in Lancashire. Professor Kyzas and his team managed to establish the service within months, and throughout the challenging covid period. The ELHT H&N Unit now produces oncological outcomes that compare favourably with any major H&N unit worldwide. Professor Kyzas has been appointed as the Clinical Director for all cancer services in ELHT, covering population of > 1M people.

    In 2021, Professor Kyzas has been awarded the highly prestigious Bronze National Clinical Excellence Award for his overall services in the NHS. He was the youngest consultant to achieve this award and the only Cypriot OMFS surgeon ever to be considered for one.

    Professor Kyzas has a long history of involvement in medical research. In 2007 he has completed his PhD thesis which has resulted in several highly cited publications in some of the most prestigious medical journals. He has participated in international collaborations for the improvement of medical research (http://progress-partnership.org/publications) and some of his papers have had a significant impact in improving research methodology. He has given several invited international lectures, and he has presented in national and international conferences. He has been a panel member for the selection committees for trainees in every level in oral and Maxillofacial Surgery in the UK. He is a regular peer-reviewer for many medical journals. He is the Lead trainer for the TIG H&N fellowship for his hospital and the Research Lead for his Deanery. He participates actively in Clinical Research, and he is the Principal Investigator for many clinical trials. He is a faculty member for the «Head and Neck resection tactics and free flap» course run by the Royal College of Surgeons of Edinburgh. He offers themed training in Head and Neck Oncological Surgery to medical students. In 2018 he was awarded the «Surgical Educator Excellence Award» by Health Education North West (HEENW). In the same year, he was nominated as doctor of the year in Northern Care Alliance.

    Professor Kyzas is the Chief Investigator of the MANTRA trial, a UK multicentre RCT with multimillion pounds NIHR funding, launched in July 2023. This is the biggest randomised controlled trial ever to be performed in the specialty of OMFS.

    As a result of his outstanding clinical and research/academic achievements, Professor Kyzas has been appointed as a visiting Professor in OMFS H&N Surgery at Edge Hill University

    In 2018 Professor Kyzas was elected as the Deputy Editor for the British Journal of Oral and Maxillofacial Surgery (BJOMS). In January 2024, Professor Kyzas started his role as Editor in Chief for the BJOMS. This is the first time that a Greek Cypriot has ever been chosen for this highly prestigious role. Professor Kyzas sits in the council of the British Association of Oral and Maxillofacial Surgeons (BAOMS).

    Professor Kyzas is a fully accredited medical expert witness and has provided hundreds of medical expert negligence reports (πραγματογνώμονας). In June 2024, Professor Kyzas has completed his Degree in Law with Honours (Άριστα), becoming a member of a very prestigious club of medical professionals with an active interest and certified knowledge in medicolegal practice.

    Professor Kyzas is a fully accredited Oral and Maxillofacial Surgeon on the specialist register of the General Medical Council (GMC) UK, the Cyprus Medical Association (Cyprus), and the Cyprus Dental Association (Cyprus). In addition, he is also fully recognised and registered as Oral Surgeon by the General Dental Council (GDC) UK. He is a fellow of the Royal College of Surgeons (FRCSEd), member of the Faculty of Surgical Trainers (MFSTEd), fellow of the British Association of Oral and Maxillofacial Surgeons (BAOMS), member of the Hellenic Society of Head and Neck Oncology (HeSHNO) and member of the European Association of Craniomaxillofacial Surgery (ECAMFS).

  • Read more
Doctor's visit
Price on request
Info